Sharae Inman, PA
Medical · Sheridan, WYNPI 1306577473
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,237 of the $3,522 with a category attached, or 63.5%. 10 manufacturers reported payments, led by Boston Scientific at 57.4% of the total. Reporting peaked in 2023 at $1,668 and has fallen 90.0% since, to $167 in 2025. Among medical clinicians in WY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $78.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Pacira Pharmaceuticals Incorporated$1K
- Medtronic$87
- AbbVie$74
- Pfizer$49
- Argenx US, Inc.$28
- plus $58 from 4 others
What the payments were for
- Travel & lodging$2,23764%
- Food & beverage$1,28536%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $2,023 |
| Pacira Pharmaceuticals Incorporated | 8 | $1,203 |
| Medtronic | 1 | $87 |
| AbbVie | 3 | $74 |
| Pfizer | 3 | $49 |
| Argenx US, Inc. | 2 | $28 |
| Amgen | 1 | $19 |
| Grifols USA, LLC | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$1,035
How this compares
$3,522 in reported general payments places this provider in the 90th percentile of 56 medical providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 67 | $41,420 |
| MovantikNaloxegol Oxalate | 83 | $38,135 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 182 | $34,701 |
| Pregabalin | 437 | $25,982 |
| OxycontinOxycodone Hcl | 34 | $18,854 |
| Buprenorphine Hcl | 422 | $18,354 |
| Buprenorphine | 53 | $14,710 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 476 | $13,172 |
| Fentanyl | 113 | $12,678 |
| Lidocaine | 84 | $9,688 |
| Gabapentin | 552 | $9,366 |
| Duloxetine Hcl | 312 | $5,870 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 190 | $5,732 |
| Tizanidine Hcl | 363 | $4,788 |
| Tramadol Hcl | 408 | $4,297 |
Paid to pharmacies, not to this prescriber.
Other medical in Sheridan
- Jessica NeauSheridan$7K
- Autumn BarrettSheridan$6K
- Jason OttoSheridan$607
- Tracy JonsSheridan$236
- Mark SandersRock Springs$5K
- John VippermanCody$5K
- Gary OttersbachCasper$4K
- Jennifer RosicsCasper$3K
- Melissa JewellRock Springs$3K
- Brittany HagerCasper$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.